Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A moderate form of autism spectrum disorder marked by more significant challenges in social communication and more noticeable restricted, repetitive behaviors, requiring substantial support for daily functioning.
Biomarker and diagnostic research for autism spectrum disorder 2 has been reported in the published literature.
No clinical trials have been registered for autism spectrum disorder 2.
6 publications have been identified in PubMed for autism spectrum disorder 2. Research spans Epidemiology / Natural History (33%), Diagnostic / Biomarker (17%), and Review / Meta-Analysis (17%).
Noppari T (2026). [PMID: 41108393](https://pubmed.ncbi.nlm.nih.gov/41108393/). *Eur J Nucl Med Mol Imaging*. [Basic Science / Preclinical]
Hanawa Y (2025). [PMID: 40395630](https://pubmed.ncbi.nlm.nih.gov/40395630/). *PCN Rep*. [Diagnostic / Biomarker]
Chen Z (2025). [PMID: 40554134](https://pubmed.ncbi.nlm.nih.gov/40554134/). *J Psychosom Res*. [Epidemiology / Natural History]
Kaye AD (2024). [PMID: 39269569](https://pubmed.ncbi.nlm.nih.gov/39269569/). *Adv Ther*. [Review / Meta-Analysis]
Chien WH (2024). [PMID: 38791584](https://pubmed.ncbi.nlm.nih.gov/38791584/). *Int J Mol Sci*. [Gene Therapy / Novel Therapeutics]
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 4:30 PM UTC
AI-curated news mentioning autism spectrum disorder 2
Updated Sep 12, 2026
A recent case report highlights a genetic association between Lhermitte-Duclos Disease and Autism Spectrum Disorder in patients with PTEN mutations. This finding contributes to the understanding of the genetic links between these conditions.
A recent study explores the role of copy number variants and cumulative genetic load in autism spectrum disorders through chromosomal microarray analysis. This research provides new insights into the genetic underpinnings of autism, potentially guiding future therapeutic strategies.
A recent study explores rare variants in purinergic P2X receptor genes (P2RX4, P2RX5, P2RX7) among individuals with autism spectrum disorder. This research may provide insights into the genetic underpinnings of autism, although further validation is needed.
The National Institutes of Health has submitted a request for review to the Office of Management and Budget regarding the information collection for Autism Spectrum Disorder research. This is part of compliance with the Paperwork Reduction Act.
A CDC report reveals that approximately 1 in 59 eight-year-old children were identified with autism in 2014 across 11 U.S. communities. This data highlights the ongoing need for awareness and resources for autism spectrum disorder.